Advanced End Period Cash Flow vs Free Cash Flow Analysis

AMS Stock

212.50 5.50 2.66%

Advanced Medical financial indicator trend analysis is way more than just evaluating Advanced Medical Sol prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Advanced Medical Sol is a good investment. Please check the relationship between Advanced Medical End Period Cash Flow and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Medical Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Advanced Medical Sol End Period Cash Flow account and Free Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Advanced Medical's End Period Cash Flow and Free Cash Flow is 0.53. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Advanced Medical Solutions, assuming nothing else is changed. The correlation between historical values of Advanced Medical's End Period Cash Flow and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Advanced Medical Solutions are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., Advanced Medical's End Period Cash Flow and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.53

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

End Period Cash Flow

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Advanced Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Advanced Medical Sol current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Medical Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Selling General Administrative is expected to grow to about 53.2 M, whereas Tax Provision is forecasted to decline to about 5 M.

	2021	2022	2023	2024 (projected)
Interest Expense	1.1M	638K	384K	250.6K
Depreciation And Amortization	8.8M	8.8M	10.8M	11.3M

Interest Expense Depreciation And Amortization

Advanced Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Current Deferred Revenue
Total Assets		0.34	0.76	0.96	1.0	0.94	-0.77	0.99	0.48	0.86	0.96	0.12	0.86	0.59	0.53	0.73	0.94	0.07	0.49	0.9	0.89	0.95	0.21	0.57	0.77	0.38
Short Long Term Debt Total	0.34		0.23	0.37	0.28	0.42	-0.06	0.23	0.77	0.25	0.38	0.07	0.25	0.37	0.22	0.71	0.24	0.81	0.68	0.63	0.25	0.29	0.47	0.38	0.27	-0.51
Other Current Liab	0.76	0.23		0.88	0.77	0.68	-0.79	0.76	0.14	0.82	0.62	0.24	0.82	0.55	0.5	0.36	0.71	-0.13	0.39	0.62	0.62	0.83	0.09	0.53	0.28	0.16
Total Current Liabilities	0.96	0.37	0.88		0.95	0.91	-0.8	0.94	0.45	0.89	0.88	0.16	0.89	0.62	0.56	0.67	0.9	0.06	0.52	0.87	0.83	0.95	0.24	0.6	0.64	0.31
Total Stockholder Equity	1.0	0.28	0.77	0.95		0.93	-0.81	1.0	0.42	0.88	0.94	0.11	0.88	0.59	0.54	0.67	0.93	0.0	0.46	0.86	0.88	0.96	0.19	0.56	0.76	0.44
Property Plant And Equipment Net	0.94	0.42	0.68	0.91	0.93		-0.64	0.9	0.62	0.77	0.93	0.04	0.77	0.71	0.65	0.78	0.85	0.23	0.66	0.91	0.79	0.87	0.28	0.7	0.75	0.33
Net Debt	-0.77	-0.06	-0.79	-0.8	-0.81	-0.64		-0.82	-0.1	-0.97	-0.57	0.11	-0.97	-0.4	-0.46	-0.23	-0.62	0.39	-0.19	-0.5	-0.55	-0.91	-0.04	-0.39	-0.56	-0.61
Retained Earnings	0.99	0.23	0.76	0.94	1.0	0.9	-0.82		0.37	0.89	0.93	0.13	0.89	0.52	0.47	0.65	0.94	-0.06	0.38	0.84	0.88	0.96	0.17	0.49	0.76	0.47
Accounts Payable	0.48	0.77	0.14	0.45	0.42	0.62	-0.1	0.37		0.28	0.57	-0.11	0.28	0.56	0.43	0.83	0.38	0.74	0.71	0.73	0.39	0.36	0.27	0.54	0.57	-0.12
Cash	0.86	0.25	0.82	0.89	0.88	0.77	-0.97	0.89	0.28		0.69	-0.06	1.0	0.45	0.48	0.44	0.71	-0.19	0.32	0.68	0.64	0.97	0.13	0.45	0.65	0.51
Non Current Assets Total	0.96	0.38	0.62	0.88	0.94	0.93	-0.57	0.93	0.57	0.69		0.15	0.69	0.6	0.49	0.82	0.95	0.23	0.54	0.92	0.93	0.83	0.23	0.56	0.79	0.27
Non Currrent Assets Other	0.12	0.07	0.24	0.16	0.11	0.04	0.11	0.13	-0.11	-0.06	0.15		-0.06	-0.04	-0.24	0.16	0.34	0.1	-0.15	0.17	0.23	0.07	0.32	-0.13	-0.38	-0.47
Cash And Short Term Investments	0.86	0.25	0.82	0.89	0.88	0.77	-0.97	0.89	0.28	1.0	0.69	-0.06		0.45	0.48	0.44	0.71	-0.19	0.32	0.68	0.64	0.97	0.13	0.45	0.65	0.51
Common Stock Total Equity	0.59	0.37	0.55	0.62	0.59	0.71	-0.4	0.52	0.56	0.45	0.6	-0.04	0.45		0.95	0.42	0.46	0.31	0.85	0.55	0.43	0.52	0.23	0.98	0.33	0.12
Common Stock Shares Outstanding	0.53	0.22	0.5	0.56	0.54	0.65	-0.46	0.47	0.43	0.48	0.49	-0.24	0.48	0.95		0.25	0.34	0.15	0.79	0.4	0.32	0.5	0.23	0.96	0.34	0.31
Non Current Liabilities Total	0.73	0.71	0.36	0.67	0.67	0.78	-0.23	0.65	0.83	0.44	0.82	0.16	0.44	0.42	0.25		0.72	0.65	0.59	0.94	0.74	0.58	0.27	0.4	0.69	-0.12
Inventory	0.94	0.24	0.71	0.9	0.93	0.85	-0.62	0.94	0.38	0.71	0.95	0.34	0.71	0.46	0.34	0.72		0.05	0.33	0.86	0.94	0.84	0.2	0.4	0.66	0.26
Other Current Assets	0.07	0.81	-0.13	0.06	0.0	0.23	0.39	-0.06	0.74	-0.19	0.23	0.1	-0.19	0.31	0.15	0.65	0.05		0.63	0.45	0.16	-0.1	0.4	0.3	0.12	-0.64
Other Stockholder Equity	0.49	0.68	0.39	0.52	0.46	0.66	-0.19	0.38	0.71	0.32	0.54	-0.15	0.32	0.85	0.79	0.59	0.33	0.63		0.61	0.36	0.39	0.35	0.89	0.37	-0.12
Total Liab	0.9	0.63	0.62	0.87	0.86	0.91	-0.5	0.84	0.73	0.68	0.92	0.17	0.68	0.55	0.4	0.94	0.86	0.45	0.61		0.85	0.8	0.29	0.52	0.73	0.06
Property Plant And Equipment Gross	0.89	0.25	0.62	0.83	0.88	0.79	-0.55	0.88	0.39	0.64	0.93	0.23	0.64	0.43	0.32	0.74	0.94	0.16	0.36	0.85		0.77	0.1	0.38	0.72	0.25
Total Current Assets	0.95	0.29	0.83	0.95	0.96	0.87	-0.91	0.96	0.36	0.97	0.83	0.07	0.97	0.52	0.5	0.58	0.84	-0.1	0.39	0.8	0.77		0.19	0.5	0.69	0.46
Short Term Debt	0.21	0.47	0.09	0.24	0.19	0.28	-0.04	0.17	0.27	0.13	0.23	0.32	0.13	0.23	0.23	0.27	0.2	0.4	0.35	0.29	0.1	0.19		0.21	0.02	-0.2
Common Stock	0.57	0.38	0.53	0.6	0.56	0.7	-0.39	0.49	0.54	0.45	0.56	-0.13	0.45	0.98	0.96	0.4	0.4	0.3	0.89	0.52	0.38	0.5	0.21		0.33	0.14
Intangible Assets	0.77	0.27	0.28	0.64	0.76	0.75	-0.56	0.76	0.57	0.65	0.79	-0.38	0.65	0.33	0.34	0.69	0.66	0.12	0.37	0.73	0.72	0.69	0.02	0.33		0.56
Current Deferred Revenue	0.38	-0.51	0.16	0.31	0.44	0.33	-0.61	0.47	-0.12	0.51	0.27	-0.47	0.51	0.12	0.31	-0.12	0.26	-0.64	-0.12	0.06	0.25	0.46	-0.2	0.14	0.56

Click cells to compare fundamentals

Advanced Medical Account Relationship Matchups

Advanced Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	227.0M	238.6M	249.5M	281.1M	289.2M	303.6M
Short Long Term Debt Total	10.4M	11.1M	9.9M	9.8M	9.1M	9.6M
Other Current Liab	6.6M	6.0M	9.2M	13.3M	13.0M	13.7M
Total Current Liabilities	17.2M	14.7M	17.0M	22.7M	21.6M	22.7M
Total Stockholder Equity	191.2M	202.2M	212.7M	236.6M	244.2M	256.4M
Property Plant And Equipment Net	27.7M	30.1M	27.4M	29.0M	29.6M	31.1M
Net Debt	(54.4M)	(42.7M)	(63.1M)	(72.5M)	(51.0M)	(48.5M)
Retained Earnings	132.5M	137.7M	151.4M	167.4M	178.5M	187.5M
Accounts Payable	7.4M	6.8M	4.9M	6.4M	6.2M	3.4M
Cash	64.8M	53.8M	73.0M	82.3M	60.2M	63.2M
Non Current Assets Total	115.2M	141.4M	134.5M	149.2M	166.8M	175.2M
Non Currrent Assets Other	(53.6M)	(133.6M)	(124.0M)	(132.4M)	136.3M	143.1M
Cash And Short Term Investments	64.8M	53.8M	73.0M	82.3M	60.2M	63.2M
Common Stock Total Equity	10.6M	10.7M	10.7M	10.8M	12.4M	9.6M
Common Stock Shares Outstanding	216.8M	217.8M	218.3M	219.5M	219.3M	163.9M
Liabilities And Stockholders Equity	227.0M	238.6M	249.5M	281.1M	289.2M	303.6M
Non Current Liabilities Total	18.6M	21.6M	19.8M	21.8M	23.4M	24.6M
Inventory	17.7M	21.0M	19.3M	27.9M	36.0M	37.8M
Other Current Assets	3.7M	4.7M	5.2M	4.0M	5.2M	3.8M
Other Stockholder Equity	36.1M	37.7M	36.8M	38.6M	32.1M	34.9M
Total Liab	35.7M	36.3M	36.8M	44.5M	45.0M	47.2M
Property Plant And Equipment Gross	27.7M	30.1M	55.6M	60.3M	64.3M	67.5M
Total Current Assets	111.8M	97.2M	115.0M	131.9M	122.3M	128.4M
Short Term Debt	1.4M	938K	256K	111K	1.2M	1.2M
Common Stock	10.7M	10.8M	10.8M	10.8M	10.9M	9.8M
Accumulated Other Comprehensive Income	12.0M	17.6M	13.7M	21.3M	22.7M	23.8M
Intangible Assets	86.9M	111.0M	107.0M	119.2M	55.9M	58.7M
Current Deferred Revenue	1.8M	319K	897K	948K	(1.2M)	(1.2M)
Net Receivables	29.4M	17.7M	17.5M	17.7M	20.9M	14.0M
Good Will	53.6M	68.9M	66.0M	70.9M	80.4M	48.3M
Other Assets	5.7M	7.7M	10.6M	937K	1.1M	1.0M
Net Invested Capital	191.9M	202.2M	212.7M	236.6M	244.2M	222.0M
Net Working Capital	94.6M	82.5M	98.0M	109.2M	100.7M	104.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Advanced Stock

Balance Sheet is a snapshot of the financial position of Advanced Medical Sol at a specified time, usually calculated after every quarter, six months, or one year. Advanced Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Advanced Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Advanced currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Advanced End Period Cash Flow vs Free Cash Flow Analysis

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Free Cash Flow

Advanced Medical fundamental ratios Correlations

Advanced Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Advanced Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Advanced Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Retained Earnings	+ 0.99	Total Assets
Common Stock	+ 0.98	Common Stock Total Equity
Total Current Assets	+ 0.97	Cash

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Total Current Assets	- 0.91	Net Debt
Retained Earnings	- 0.82	Net Debt
Net Debt	- 0.81	Total Stockholder Equity
Net Debt	- 0.8	Total Current Liabilities